Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Acta Derm Venereol ; 81(4): 298-300, 2001.
Article de Anglais | MEDLINE | ID: mdl-11720182

RÉSUMÉ

A hereditary and an acquired type of C1-esterase inhibitor deficiency have been described. Manifestations characteristic of both forms include recurrent subcutaneous and submucosal angiooedema. Acquired C1-esterase inhibitor deficiency has been observed in association with lymphoproliferative disorders, malignancy, autoimmune diseases and infections. We report on a case with the acquired form of the disease accompanied by leucocytoclastic vasculitis. Treatment with antimalarial agents resulted in complete resolution of symptoms and signs. Furthermore, C1-esterase inhibitor concentration and activity, as well as C1 levels, all returned to normal.


Sujet(s)
Angioedème/enzymologie , Protéines inhibitrices de la fraction C1 du complément/déficit , Vascularite leucocytoclasique cutanée/enzymologie , Adulte , Angioedème/traitement médicamenteux , Antipaludiques/usage thérapeutique , Chloroquine/usage thérapeutique , Protéines du système du complément , Femelle , Humains , Hydroxychloroquine/usage thérapeutique , Résultat thérapeutique , Vascularite leucocytoclasique cutanée/traitement médicamenteux
2.
Neuroimmunomodulation ; 9(1): 49-54, 2001.
Article de Anglais | MEDLINE | ID: mdl-11435752

RÉSUMÉ

OBJECTIVES: The aim of the present study was to investigate the role of soluble adhesion molecules in the pathogenesis of multiple sclerosis (MS) and systemic lupus erythematosus (SLE) with demyelinating syndrome. METHODS: Paired cerebrospinal fluid (CSF) and serum samples were analysed by an ELISA method to determine the concentrations of sVCAM-1, sICAM-1 and sL-selectin. Intrathecal syntheses of the adhesion molecules were calculated. RESULTS: Elevated serum and CSF concentrations of sVCAM-1 were present in all patient groups. Intrathecal synthesis of sVCAM-1 was present in the relapsing-remitting and secondary progressive forms of MS. Intrathecal synthesis of sICAM-1 was observed in all clinical forms of MS. MS patients with progressive forms of the disease and SLE patients were characterised by intrathecal synthesis of sL-selectin. CONCLUSIONS: The data presented suggest that (1) blood-brain barrier damage can be assumed both in systemic disease and organ-specific disease (sVCAM-1), (2) clinical forms of MS differ from each other in respect to concentrations of adhesion molecules and (3) similar immunological events in the central nervous system of SLE patients with demyelinating syndrome and progressive forms of MS can be assumed (sL-selectin).


Sujet(s)
Maladies auto-immunes/physiopathologie , Barrière hémato-encéphalique , Protéines du liquide céphalorachidien/analyse , Molécule-1 d'adhérence intercellulaire/analyse , Sélectine L/analyse , Lupus érythémateux disséminé/physiopathologie , Sclérose en plaques/physiopathologie , Molécule-1 d'adhérence des cellules vasculaires/analyse , Adulte , Sujet âgé , Maladies auto-immunes/sang , Maladies auto-immunes/liquide cérébrospinal , Maladies auto-immunes/immunologie , Sédimentation du sang , Encéphale/anatomopathologie , Études de cohortes , Maladies démyélinisantes , Évolution de la maladie , Femelle , Humains , Molécule-1 d'adhérence intercellulaire/sang , Molécule-1 d'adhérence intercellulaire/liquide cérébrospinal , Sélectine L/sang , Sélectine L/liquide cérébrospinal , Lupus érythémateux disséminé/sang , Lupus érythémateux disséminé/liquide cérébrospinal , Lupus érythémateux disséminé/immunologie , Mâle , Adulte d'âge moyen , Sclérose en plaques/sang , Sclérose en plaques/liquide cérébrospinal , Sclérose en plaques/classification , Sclérose en plaques/immunologie , Études prospectives , Solubilité , Molécule-1 d'adhérence des cellules vasculaires/sang , Molécule-1 d'adhérence des cellules vasculaires/liquide cérébrospinal
3.
Acta Neurol Scand ; 102(2): 114-7, 2000 Aug.
Article de Anglais | MEDLINE | ID: mdl-10949528

RÉSUMÉ

Soluble L-selectin (sL-selectin) concentrations were measured in paired samples of serum and cerebrospinal fluid by an ELISA method. Patients with several forms of multiple sclerosis (MS) and systemic lupus erythematosus with central nervous system involvement (SLE-CNS) were investigated. Elevated CSF sL-selectin concentrations were found in patients with SLE-CNS (7.62 +/- 3.31 ng/ml) and with relapsing-remitting form of MS (6.99 +/- 4.72 ng/ml) compared to the control group (4.00 +/- 0.95 ng/ml). The data presented suggest some similarities between inflammatory/immunological events in the central nervous system in patients with SLE-CNS and relapsing-remitting form of MS. Immunological heterogeneity in MS is suspected.


Sujet(s)
Encéphale/immunologie , Sélectine L/métabolisme , Vascularite lupique du système nerveux central/sang , Vascularite lupique du système nerveux central/liquide cérébrospinal , Sclérose en plaques récurrente-rémittente/sang , Sclérose en plaques récurrente-rémittente/liquide cérébrospinal , Adulte , Sujet âgé , Études cas-témoins , Test ELISA , Femelle , Humains , Sélectine L/sang , Sélectine L/liquide cérébrospinal , Vascularite lupique du système nerveux central/métabolisme , Mâle , Adulte d'âge moyen , Sclérose en plaques/sang , Sclérose en plaques/liquide cérébrospinal , Sclérose en plaques récurrente-rémittente/métabolisme , Statistique non paramétrique
4.
Acta Neurol Scand ; 99(2): 95-9, 1999 Feb.
Article de Anglais | MEDLINE | ID: mdl-10071167

RÉSUMÉ

The concentration of soluble vascular cell adhesion molecules (sVCAM-1) of serum and cerebrospinal fluid (CSF) was measured in clinically selected multiple sclerosis (MS) and systemic lupus erythematosus (SLE) patients, using an ELISA assay. The mean sVCAM-1 concentration in the serum of SLE patients was higher than normal. The mean CSF sVCAM-1 concentration was increased in the MS as in the SLE group. On analysis, the data suggests that there are some similarities in the immunological effects of these two different diseases of the central nervous system. A longitudinal analysis of the CSF is requested.


Sujet(s)
Lupus érythémateux disséminé/diagnostic , Sclérose en plaques/diagnostic , Molécule-1 d'adhérence des cellules vasculaires/liquide cérébrospinal , Adolescent , Adulte , Sujet âgé , Test ELISA , Femelle , Humains , Études longitudinales , Lupus érythémateux disséminé/immunologie , Mâle , Adulte d'âge moyen , Sclérose en plaques/immunologie , Sensibilité et spécificité
5.
Orv Hetil ; 133(14): 841-5, 1992 Apr 05.
Article de Hongrois | MEDLINE | ID: mdl-1522987

RÉSUMÉ

Studying the gene polymorphism of serum amyloid P a common constituent of amyloid deposits two restriction fragment length polymorphism patterns were found among Hungarian rheumatoid arthritis (RA), juvenile rheumatoid arthritis (JRA), systemic lupus erythematosus (SLE) patients and healthy controls. Although no direct connection between DNA polymorphism and the frequency of amyloidosis in three patient groups was found, a marked predominance of the heterozygosity in all studied groups has been described. Authors found close correlation between the serum levels of SAP and CRP in juvenile rheumatoid arthritis, but failed to find the same correlation in SLE and healthy controls. Moreover, the serum level of CRP of heterozygous patients were significantly higher than that of homozygous patients within the juvenile rheumatoid arthritis patient groups.


Sujet(s)
Amyloïde/sang , Arthrite juvénile/sang , Maladies auto-immunes/sang , Lupus érythémateux disséminé/sang , Arthrite juvénile/génétique , Arthrite juvénile/immunologie , Maladies auto-immunes/génétique , Maladies auto-immunes/immunologie , Protéine C-réactive/analyse , Hétérozygote , Homozygote , Humains , Lupus érythémateux disséminé/génétique , Lupus érythémateux disséminé/immunologie , Biologie moléculaire , Polymorphisme génétique
6.
Orv Hetil ; 130(5): 215-9, 1989 Jan 29.
Article de Hongrois | MEDLINE | ID: mdl-2644607

RÉSUMÉ

(SLE) One hundred patients suffering from systemic lupus erythematosus (SLE) were examined by clinical, non invasive cardiological, radiological and laboratory methods. Valve diseases were revealed by M-mode echocardiographic examination in 17 patients. 14 patients had various conduction disturbances. Out of the remaining 83 patients not having any valve disease, systolic dysfunction of the myocardium was detectable in 17 persons and pericardial effusion in 3 persons. Spirometric alterations have been found in 64 persons and cor pulmonale has been diagnosed in 8 persons.


Sujet(s)
Cardiopathies/étiologie , Lupus érythémateux disséminé/complications , Coeur pulmonaire/étiologie , Échocardiographie , Cardiopathies/diagnostic , Valvulopathies/diagnostic , Valvulopathies/étiologie , Humains , Épanchement péricardique/diagnostic , Épanchement péricardique/étiologie , Coeur pulmonaire/diagnostic , Spirométrie
7.
Clin Rheumatol ; 7(4): 514-9, 1988 Dec.
Article de Anglais | MEDLINE | ID: mdl-3246135

RÉSUMÉ

Patients with Sjögren's syndrome were treated with vitamin A (100,000 U) daily during a two-week period. The vitamin treatment significantly elevated their ADCC and NK activity. The lymphocyte blast transformation, however was not noticeably changed. After the treatment, the retinyl-ester and retinol level of the plasma significantly increased as did the plasma level of vitamin E. The level of TBA reactive substances (malondialdehyde) in the plasma increased, whilst the glutathione peroxidase and catalase activity of erythrocytes decreased. The activity of the plasma glutathione peroxidase increased, but not significantly.


Sujet(s)
Peroxydation lipidique/effets des médicaments et des substances chimiques , Syndrome de Gougerot-Sjögren/traitement médicamenteux , Rétinol/usage thérapeutique , Cytotoxicité à médiation cellulaire dépendante des anticorps/effets des médicaments et des substances chimiques , Femelle , Humains , Cellules tueuses naturelles/effets des médicaments et des substances chimiques , Activation des lymphocytes/effets des médicaments et des substances chimiques , Malonaldéhyde/sang , Adulte d'âge moyen , Syndrome de Gougerot-Sjögren/immunologie , Syndrome de Gougerot-Sjögren/métabolisme , Vitamine E/sang
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE